Apr 9, 2019

Elekta invests in iRT Systems Search for content, post, videos The company has purchased a minority stake in the German company iRT Systems, in order to improve its quality assurance (QA) offering to clinics and hospitals. For the past six years, iRT Systems has developed the Integral Quality Monitor (IQM) system in cooperation with Princess Margaret Cancer Centre, part of the University Health Network (UHN), in Toronto, Canada. IQM is the first verification system available on the market that monitors the delivered treatment while comparing it to the planned treatment in real time. IQM is integrated into the treatment workflow, acquiring high quality data automatically without user interaction, states the company in its press release. “Elekta relentlessly pursues the advancement of treatment quality assurance – through innovation, collaboration or procurement – by elevating quality control at all stages of the workflow,” said Maurits Wolleswinkel, Head of Portfolio and Chief Strategy Officer at Elekta. “With our stake in iRT, we can help ensure that all oncology departments can do so, more accurately, efficiently and reliably, by using IQM.” IQM has CE mark, FDA 510(k) clearance as well as regulatory approvals in Canada and Australia and other markets. Advertising Recent comments September 23, 2014 Finnish health technology company Mega Electronics has signed a co-operation agreement with two Chinese medical device companies. Huafu Medical and Mercer Medical will start distribution of Mega Electronics’ remote-readable Faros ECG monitoring devices, reports Good News Finland. The Faros monitoring device is used to measure a person’s ECG. The goal is to  a comprehensive distribution network… November 1, 2017 Norwegian Biim Ultrasound announced October 27th that their Biim linear probe and Biim software app received FDA clearance as a diagnostic ultrasound system. The Biim Diagnostic Ultrasound System is intended for diagnostic ultrasound imaging for the human body. Specific clinical applications include musculoskeletal, needle guidance, pediatric, peripheral vessel and small organs.… April 26, 2016 Bactiguard and BioInteractions have received a European research grant aimed at developing a new generation of vascular access catheters, with new bio-smart materials for medical devices. The technology will be developed in a joint project with BioInteractions, UK and Bactiguard, financed by VINNOVA and Innovate UK. Some of the most… July 25, 2018 The company has registered Dignitana S.r.l as a new entity in Italy, a wholly-owned subsidiary of Dignitana AB. The entity will function under the leadership of Dignitana AB and with this registration the company can now finalize contracts for the sale of 3 machines in Italy. “We are excited to announce… Editor in Chief